Loading data for OSRH — first visit, this takes a few seconds.
OSR Health Inc. (OSRH)
NasdaqCM: OSRH
· Real-Time Price · USD
0.28
-0.01 (-3.45%)
At close: Aug 21, 2026, 8:00 PM
0.27
-0.94%
After-hours: 7:58 PM
The price, the headline numbers and the latest news, in one place.
OSR Health Inc. (OSRH) Stock Price, Analysis & Data
-3.45% (1D)
No data available
| Bid | 0.23 |
| Market Cap | 9.73M |
| Revenue (ttm) | 1.81M |
| Net Income (ttm) | -10.73M |
| n/a | |
| -0.3 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.09 |
| P/S (ttm) | 5.38 |
| Earnings Date | n/a |
| Ask | 0.35 |
| Volume | 4,817,021 |
| Avg. Volume (20D) | 9,686,591 |
| Open | 0.30 |
| Previous Close | 0.29 |
| Day's Range | 0.27 - 0.33 |
| 52-Week Range | 0.25 - 1.24 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OSRH
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antig...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 21, 2023
Employees 22
Stock Exchange NasdaqCM
Ticker Symbol OSRH
Website https://osr-holdings.com
Financial Performance
In 2025, OSR Health's revenue was 2.91M, a decrease of -17.69% compared to the previous year's 3.53M. Earnings were -18.01M, an increase of 74.37%.
Financial StatementsEarnings Surprise
OSR Health has released their quarterly earnings on Mar 31, 2026:
- Revenue of $484.06K misses estimates by $0, with -36.41% YoY decline.
- EPS of -0.16 misses estimates by -0.06, with -Infinity% YoY decline.